Comments
Loading...
Aprea Therapeutics (APRE) Forecast
NewsEarningsAprea Therapeutics (APRE) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAprea Therapeutics (NASDAQ:APRE) Stock Quotes, Forecast and News Summary
Aprea Therapeutics Stock (NASDAQ: APRE) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Aprea Therapeutics (APRE) stock?
You can purchase shares of Aprea Therapeutics (NASDAQ:APRE) through any online brokerage.
Who are Aprea Therapeutics (APRE) competitors?
Other companies in Aprea Therapeutics’s space includes: NKGen Biotech (NASDAQ:NKGN), HOOKIPA Pharma (NASDAQ:HOOK), CARISMA Therapeutics (NASDAQ:CARM), Coeptis Therapeutics (NASDAQ:COEP) and Nanoviricides (AMEX:NNVC).
What is the forecast, or price target, for Aprea Therapeutics (APRE) stock?
Aprea Therapeutics has a consensus price target of $10.60.
What is the current price for Aprea Therapeutics (APRE)?
The stock price for Aprea Therapeutics (NASDAQ: APRE) is $4.0681 last updated January 23, 2025 at 1:34 PM EST.
Does Aprea Therapeutics (APRE) pay a dividend?
There are no upcoming dividends for Aprea Therapeutics.
When is Aprea Therapeutics (NASDAQ:APRE) reporting earnings?
Aprea Therapeutics’s Q4 earnings are confirmed for Tuesday, March 25, 2025.
Is Aprea Therapeutics (APRE) going to split?
There is no upcoming split for Aprea Therapeutics.
What sector and industry does Aprea Therapeutics (APRE) operate in?
Aprea Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.